Articles related to EYE DISEASES

Patients taking semaglutide for diabetes were more than four times more likely to develop NAION compared to those on other diabetes medications, while those using it for obesity had a seven-fold increased risk.

A recent phase 3 trial demonstrates that a combination therapy of belantamab mafodotin, bortezomib, and dexamethasone leads to significantly longer progression-free survival in patients with relapsed or refractory multiple myeloma compared to a regimen including daratumumab.

Endophthalmitis is a severe infection that can threaten vision. In a recent case, a patient’s vision did not improve despite treatment with intravitreal antimicrobial agents and an 8-week course of intravenous cefazolin. This underscores the importance of early detection and comprehensive treatment strategies.

Xdemvy, backed by robust clinical trials, offers a new, targeted treatment option for Demodex blepharitis. The FDA-approved solution is expected to be available by the end of August 2023.

This case study highlights the importance of accurate diagnosis and monitoring in retinoschisis, particularly given its potential to lead to complications like retinal detachment. Stay updated on best practices for management and treatment.

Dry eye disease (DED), ocular surface disease (OSD), and other cornea and anterior segment diseases can cause patients to experience a diverse range of symptoms. The cornea is the most densely innervated tissue and is therefore an important target for therapeutics and research. Transient receptor potential (TRP) channels are signaling channels that play roles in signaling physiological processes, and TRP melastatin member 8 (TRPM8) is a cold-sensing receptor found on nerve endings of the ophthalmic branch of the trigeminal nerve. TRPM8 channels sense cooling changes in corneal temperature and are activated by evaporative cooling and hyperosmolarity, leading to stimulation of tear production, which may be why eyes water on cold days and in patients with dry eye. Understanding the interaction between symptoms, ocular healing, and dysfunctions that occur in this process can help optometrists care for their patients more effectively.